Why is Ipca Laboratories Ltd ?
- The company has declared positive results for the last 9 consecutive quarters
- OPERATING CF(Y) Highest at Rs 1,378.12 Cr
- ROCE(HY) Highest at 19.55%
- PBT LESS OI(Q) At Rs 546.82 cr has Grown at 47.3% (vs previous 4Q average)
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Along with generating 38.61% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
How much should you buy?
- Overall Portfolio exposure to Ipca Labs should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Ipca Labs for you?
Medium Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at Rs 1,378.12 Cr
Highest at 19.55%
At Rs 546.82 cr has Grown at 47.3% (vs previous 4Q average
Highest at Rs 6.00
Highest at Rs 564.59 cr
Highest at 4.79 times
Highest at Rs 2,788.10 cr
Highest at Rs 669.51 cr.
Highest at 24.01%
Highest at Rs 401.89 cr.
Highest at Rs 15.84
Here's what is working for Ipca Labs
Operating Cash Flows (Rs Cr)
PBT less Other Income (Rs Cr)
Net Sales (Rs Cr)
Operating Profit (Rs Cr)
Operating Profit to Sales
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
PAT (Rs Cr)
EPS (Rs)
Cash and Cash Equivalents
Debtors Turnover Ratio
DPS (Rs)






